- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
KMS Medisurgi's board approved audited financial results for the half-year and year ended March 31, 2026. Revenue was 12.21 Cr, profit 0.25 Cr. Auditors issued a qualified opinion on employee benefits and couldn't comment on Rs 2.54 Cr closing stock due to record reconciliation.